Dublin, April 25, 2022 (GLOBE NEWSWIRE) -- The "Home DNA Test Kit Market Opportunity Forecast 2028" report has been added to ResearchAndMarkets.com's offering.
The global home genetic testing kit market is expected to surpass US$ 10 Billion by 2028
The report covers a detailed study of home genetic testing kit market size, growth and share, trends, consumption, segments, application, and forecast till 2028. In addition to this, the report also provides comprehensive analysis on the availability of home genetic testing kit across various geographical regions along with their commercial information.
Home DNA Test Kit Market Opportunity Forecast 2028 Report Highlights:
- Global Home DNA Test Kit Market Opportunity > USD 10 Billion
- US Dominating Global DNA Test Kit Market > 20%
- Kits Availability & Price Analysis by Company, Country & Indication
- Global Home Genetic Testing Kit Market by Application: Ancestry, Nutrigenomics, Parenting, Chronic Diseases
- Global Home Genetic Testing Kit Market by Country: US, UK, china, India, Japan, South Korea, Taiwan, Singapore, Malaysia, Turkey, Russia, Canada, Middle East, Australia
- Global & Regional Market Forecast Till 2028
In last few decades, the field of genetics has witnessed rapid evolution which has eventually led to the development of genetic tests. In recent times, home genetic testing kits have entered the market which can be done at home without the prescription of healthcare professional.
The introduction of home genetic testing kit has empowered people and gave them a feeling of personal control in improving the quality of their lives. It allows the rapid diagnosis of disorders when public or other private healthcare resources are in short supply. Till date, several home genetic testing kits have entered the global market which provides insights on various things including genetic disease risk analysis, personal wellbeing, ancestry, diet, nutrition, parenting, and others.
One of the early players in home genetic testing kit market is 23andMe which has been known for its at-home DNA testing kit that only requires customers to mail in a little tube of saliva in order to gain useful insight into their genetic predispositions.
Other private companies that are pushing the innovation edge and warrant watching include companies like Forward, which is a subscription-based service that combines DNA sequencing, AI, full-body scanning, and wearable's for mobile health monitoring along with instant access to medical care via smartphone app. The other key players in the market include Everlywell, Ancestry, MapmyGenome, EasyDNA, MedGenome, DNAwise, DNA labs, Genes2me, and others.
Further, the arrival of COVID-19 pandemic has also pushed the home test kits market during the past two years. The rising COVID-19 cases globally have encouraged several pharmaceutical companies to develop cost-effective and easily available kit for diagnosis of the virus.
In November 2020, Lucira COVID-19 All-In-One Test Kit was the first COVID-19 diagnostic kit for self-testing at home and that provides rapid results. More recently in October 2021, FDA issued EUA for the Acon Laboratories Flowflex COVID-19 home test, which is an over-the-counter antigen test.
Cancer has a major impact on society across the world. It is one of the leading causes of death across the globe and is more prevalent in developed and emerging markets. On the basis of application, cancer diagnostic home genetic testing kits occupy the major share in the market.
The rise in geriatric population and subsequent increase in the prevalence of cancer will drive the segment during the forthcoming years. In addition, initiatives by government and other organizations to spread cancer awareness and surge in number of home genetic cancer testing kits in developed countries will also boost the growth of market during forthcoming years.
In last few years, there have been rising collaborations, partnerships, and strategic alliances among pharmaceutical companies in global home genetic testing kit market. For instance, Myriad Genetics announced strategic collaboration with Illumina for Illumina to create a kit based version of the myChoice diagnostic test for international markets.
The agreement between the companies combines companion diagnostics and next generation sequencing to advance comprehensive genomic profiling of tumor samples and improved outcomes in oncology. In addition to this, South Korea's leading mobile carrier SK Telecom has collaborated with Macrogen to develop artificial intelligence backed genome analysis solution. Under this agreement, SK Telecom plans to set up system that analyzes, cumulates, and manages genomic data and medical information owned by Macrogen using artificial intelligence.
Key Topics Covered:
1. Introduction to Home Genetic Testing Kits
1.1 Overview
1.2 Historical Perspective
2. Home Genetic Testing Kits Availability & Price Analysis by Company, Country & Indication
3. Global Home Genetic Testing Kit Market
3.1 Ongoing Trends Boosting Growth of Market
3.2 Market Acceptability Size & Volume
4. Global Home Genetic Testing Kit Market by Application
4.1 Ancestry
4.2 Nutrigenomics
4.3 Parenting
4.4 Chronic Diseases
5. US Home Genetic Testing Kits Market
5.1 Current Market Trends
5.2 Market Acceptability Size & Volume
5.3 Market by Product Applications
6. India Home Genetic Testing Kits Market
6.1 Ongoing Market Trends
6.2 Market Acceptability Size & Volume
7. UK Home Genetic Testing Kits Market
7.1 Ongoing Market Trends
7.2 Market Acceptability Size & Volume
8. China Home Genetic Testing Kits Market
8.1 Current Market Trends
8.2 Market Acceptability Size & Volume
9. Japan Home Genetic Testing Kit Market
9.1 Current Market Trends
9.2 Market Acceptability Size & Volume
10. South Korea Home Genetic Testing Kit Market
10.1 Current Market Trends
10.2 Market Acceptability Size & Volume
11. Europe Home Genetic Testing Kit Market by Countries
11.1 Germany
11.2 France
11.3 Italy
11.4 Spain
12. Taiwan Home Genetic Testing Kit Market
12.1 Ongoing Market Trends
12.2 Market Acceptability Size & Volume
13. Singapore Home Genetic Testing Kit Market
13.1 Ongoing Market Trends
13.2 Market Acceptability Size & Volume
14. Malaysia Home Genetic Testing Kit Market
14.1 Ongoing Market Trends
14.2 Market Acceptability Size & Volume
15. Turkey Home Genetic Testing Kit Market
15.1 Ongoing Market Trends
15.2 Market Acceptability Size & Volume
16. Russia Home Genetic Testing Kit Market
16.1 Ongoing Market Trends
16.2 Market Acceptability Size & Volume
17. Canada Home Genetic Testing Kit Market
17.1 Ongoing Market Trends
17.2 Market Acceptability Size & Volume
18. Australia Home Genetic Testing Kit Market
18.1 Ongoing Market Trends
18.2 Market Acceptability Size & Volume
19. Middle East Home Genetic Testing Kit Market
19.1 Ongoing Market Trends
19.2 Market Acceptability Size & Volume
20. Competitive Landscape
20.1 23andMe
20.2 Ancestry
20.3 Color Genomics
20.4 EasyDNA
20.5 Gene by Gene
20.6 Illumina
20.7 LivingDNA
20.8 Mapmygenome
20.9 MyHeritageDNA
20.10 SelfDecode
20.11 Veritas Genetics
For more information about this report visit https://www.researchandmarkets.com/r/4gvcdh
